SPECIAL OFFER : 25% Super Discount For All !
Global Oncology Cancer Drugs Market Trend & Segmentation By Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy, and Hormonal Therapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, and Others), By Region (North America, Europe, Asia Pacific, Middle East & Africa and Latin America); Trend Analysis, Market Competition Scenario & Outlook, 2016-2026
- Published Date: January 2020
- Report ID: BWC19381
- Available Format: PDF
- Page: 210
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Sources
2.2. Quantitative Research
2.2.1. Primary & Secondary Sources
2.3. Breakdown of Primary Research Respondents, By Region
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents
2.5. Market Size Estimation
2.6. Assumption for the Study
2.7. Market Breakdown & Data Triangulation
3. Executive Summary
4. Global Oncology/Cancer Drugs Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape
4.4. Regulatory Framework
4.5. Company market share analysis, 2019
4.6. Porter’s Five forces analysis
4.6.1. Bargaining Power of Suppliers
4.6.2. Bargaining Power of Buyers
4.6.3. Threat of New Entrants
4.6.4. Threat of Substitutes
4.6.5. Intensity of Rivalry
5. Global Oncology/Cancer Drugs Market Overview
5.1. Market Size & Forecast 2016-2026
5.1.1. By Value (USD)
5.2. Market Share & Forecast
5.2.1. By Drug Class Type
5.2.1.1. Chemotherapy
5.2.1.2. Targeted Therapy
5.2.1.3. Immunotherapy (Biologic Therapy)
5.2.1.4. Hormonal Therapy
5.2.2. By Indication
5.2.2.1. Lung Cancer
5.2.2.2. Stomach Cancer
5.2.2.3. Colorectal Cancer
5.2.2.4. Breast Cancer
5.2.2.5. Prostate Cancer
5.2.2.6. Liver Cancer
5.2.2.7. Esophagus Cancer
5.2.2.8. Cervical Cancer
5.2.2.9. Kidney Cancer
5.2.2.10. Bladder Cancer
5.2.2.11. Other Cancer
5.2.3. By Region
5.2.3.1. North America
5.2.3.2. Europe
5.2.3.3. Asia Pacific
5.2.3.4. Latin America
5.2.3.5. Middle East & Africa
6. North America Oncology/Cancer Drugs Market
6.1. Market Size & Forecast 2016-2026
6.1.1. By Value (USD)
6.2. Market estimates & forecast
6.2.1. By Class Type
6.2.2. By Indication
6.2.3. By Country
6.2.3.1. U.S
6.2.3.2. Canada
7. Europe Oncology/Cancer Drugs Market
7.1. Market Size & Forecast 2016-2026
7.1.1. By Value (USD)
7.2. Market estimates & forecast
7.2.1. By Class Type
7.2.2. By Indication
7.2.3. By Country
7.2.3.1. Germany
7.2.3.2. U.K
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Rest of Europe
8. Asia Pacific Oncology/Cancer Drugs Market
8.1. Market Size & Forecast 2016-2026
8.1.1. By Value (USD)
8.2. Market estimates & forecast
8.2.1. By Class Type
8.2.2. By Indication
8.2.3. By Country
8.2.3.1. China
8.2.3.2. India
8.2.3.3. Japan
8.2.3.4. South Korea
8.2.3.5. Rest of APAC
9. Latin America Oncology/Cancer Drugs Market
9.1. Market Size & Forecast 2016-2026
9.1.1. By Value (USD)
9.2. Market estimates & forecast
9.2.1. By Class Type
9.2.2. By Indication
9.2.3. By Country
9.2.3.1. Brazil
9.2.3.2. Mexico
9.2.3.3. Argentina
9.2.3.4. Rest of Latin America
10.Middle East & Africa Oncology/Cancer Drugs Market
10.1. Market Size & Forecast 2016-2026
10.1.1. By Value (USD)
10.2. Market estimates & forecast
10.2.1. By Class Type
10.2.2. By Indication
10.2.3. By Country
10.2.3.1. Saudi Arabia
10.2.3.2. UAE
10.2.3.3. South Africa
10.2.3.4. Rest of MEA
11.Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)*
11.1. AbbVie Inc.
11.2. Astellas Pharma, Inc.
11.3. AstraZeneca PLC
11.4. Bristol-Myers Squibb Company
11.5. Celgene Corporation
11.6. F. Hoffmann-La Roche Ltd.
11.7. Johnson & Johnson (Janssen Global Services, LLC,)
11.8. Merck & Co., Inc.
11.9. Novartis AG
11.10. Pfizer Inc.
11.11. Other Prominent Players
*Financial Details Not Be Captured in Case of Unlisted Companies
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Coustom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.